These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 2738623)
1. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. Moertel CG; Rubin J; Kvols LK J Clin Oncol; 1989 Jul; 7(7):865-8. PubMed ID: 2738623 [TBL] [Abstract][Full Text] [Related]
2. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour. Basser RL; Lieschke GJ; Sheridan WP; Fox RM; Green MD Aust N Z J Med; 1991 Dec; 21(6):875-8. PubMed ID: 1726359 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon]. Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326 [TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic carcinoid tumour with recombinant interferon alfa. Joensuu H; Kumpulainen E; Gröhn P Eur J Cancer; 1992; 28A(10):1650-3. PubMed ID: 1382493 [TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha. Doberauer C; Mengelkoch B; Kloke O; Wandl U; Niederle N Acta Oncol; 1991; 30(5):603-5. PubMed ID: 1892678 [TBL] [Abstract][Full Text] [Related]
6. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. Oberg K; Funa K; Alm G N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor. Smith DB; Scarffe JH; Wagstaff J; Johnston RJ Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534 [TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity. Oberg K; Alm G; Magnusson A; Lundqvist G; Theodorsson E; Wide L; Wilander E J Natl Cancer Inst; 1989 Apr; 81(7):531-5. PubMed ID: 2466128 [TBL] [Abstract][Full Text] [Related]
9. Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Välimäki M; Järvinen H; Salmela P; Sane T; Sjöblom SM; Pelkonen R Cancer; 1991 Feb; 67(3):547-9. PubMed ID: 1702352 [TBL] [Abstract][Full Text] [Related]
10. Treatment of carcinoid syndrome with recombinant interferon alpha-2a. Di Bartolomeo M; Bajetta E; Zilembo N; de Braud F; Di Leo A; Verusio C; D'Aprile M; Scanni A; Barduagni M; Barduagni A [corrected to Barduagni M] Acta Oncol; 1993; 32(2):235-8. PubMed ID: 7686766 [TBL] [Abstract][Full Text] [Related]
11. Metastatic carcinoid tumors and the malignant carcinoid syndrome. Kvols LK Ann N Y Acad Sci; 1994 Sep; 733():464-70. PubMed ID: 7978896 [No Abstract] [Full Text] [Related]
12. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome. Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Moertel CG; Hanley JA Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982 [TBL] [Abstract][Full Text] [Related]
14. A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour. Veenhof CH; de Wit R; Taal BG; Dirix LY; Wagstaff J; Hensen A; Huldij AC; Bakker PJ Eur J Cancer; 1992; 28(1):75-8. PubMed ID: 1373635 [TBL] [Abstract][Full Text] [Related]
15. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization. Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO Scand J Gastroenterol; 1989 Sep; 24(7):787-95. PubMed ID: 2477894 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b]. Linkesch M; Kuzmits R; Geyer G Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566 [TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. Oberg K; Norheim I; Lind E; Alm G; Lundqvist G; Wide L; Jonsdottir B; Magnusson A; Wilander E Cancer Treat Rep; 1986 Nov; 70(11):1297-304. PubMed ID: 2429764 [TBL] [Abstract][Full Text] [Related]